University of Basel

Department of
Biomedicine

Search

News

RSS
New Findings on Immune Dysfunction and Lymphoma Risk (Binder Lab)
/ News, Research

New Findings on Immune Dysfunction and Lymphoma Risk (Binder Lab)

Lymphocytes are essential for health, but when they malfunction, they can cause immune deficiencies, autoimmune diseases, or cancer. Autoimmune disorders and certain blood cancers, such as non-Hodgkin’s lymphoma, share similar disease…

DBM Newsletter Issue 09

Department of Biomedicine Newsletter No. 9

We are pleased to announce the release of the ninth edition of our DBM Newsletter. We hope you enjoy reading it!

Stock Image
/ News, Research

Exploring the Impact of Drugs on Cellular Metabolism (Zampieri Lab)

Researchers in Mattia Zampieri's Systems Pharmacology and Biology of Metabolism lab have developed a novel method to study how thousands of active compounds simultaneously affect cellular metabolism. This approach offers new insights into…

.
/ News, People

Two SNSF Advanced Grants for the Department of Biomedicine

Cancer researcher Prof. Dr. Mohamed Bentires-Alj and diabetes researcher Prof. Dr. Marc Donath have each been awarded one of the highly competitive grants from the Swiss National Science Foundation (SNSF). Both projects address socially…

CD52-stabilization as a potential target for immunotherapy in liver cirrhosis. (Symbolic image: ChatGPT)
/ News, Research

Unveiling CD52 on monocytes: A New Frontier in Combating Immune Dysfunction in Cirrhosis (Bernsmeier Lab)

The Department of Biomedicine (DBM) is pleased to announce an important new study led by Anne Geng, under the supervision of Christine Bernsmeier, in collaboration with researchers at the University Hospital Basel and colleagues in St.…

Social Media

To top